Table 5.
Spot Sign Score* |
Mean/Median LOS, days† |
Mean mRS in All Patients‡ |
Mean mRS in Survivors‡ |
In-Hospital Mortality, % |
Poor Outcome,§ % |
---|---|---|---|---|---|
0 | |||||
n = 440 | 10.1 / 6 | 3.2 | 2.3 | 24 | 29 |
ns = 334 | |||||
1 | |||||
n = 32 | 10.4 / 8 | 4.2 | 3.0 | 41 | 42 |
ns = 19 | |||||
2 | |||||
n = 46 | 15.3 / 13 | 4.8 | 3.1 | 59 | 47 |
ns = 19 | |||||
3 | |||||
n = 33 | 19.1 / 19 | 5.0 | 3.4 | 61 | 54 |
ns = 13 | |||||
4 | |||||
n = 22 | 19.8 / 17 | 5.4 | 4.3 | 64 | 75 |
ns = 8 | |||||
AUC | n/a | n/a | n/a | 0.64 | 0.56 |
(95% CI) | (0.60–0.68) | (0.51–0.61) | |||
p-value | n/a | n/a | n/a | <0.0001 | 0.04 |
A score of zero indicates that no spot sign is identified in the CT angiogram.
Length of hospital stay among the 393 survivors.
Modified Rankin Scale at 3-month follow-up.
Defined as a modified Rankin Scale of ≥4 at 3-month follow-up among the 393 survivors.
ICH: intracerebral hemorrhage; LOS: length of hospital stay; mRS: modified Rankin Scale; n: number of patients within spot sign score group in the entire cohort; ns: number of patients within spot sign score group among survivors; AUC: area under the curve after receiver operating characteristic analysis; CI: confidence interval; n/a: not applicable.